BIOA
BioAge Labs, Inc.
$22.70
-0.08 (-0.35%)
At close · Jul 15
Market Cap
$985.07M
Shares
44,452,734
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$9M
FY2025
Net Income
-$80.61M
-13.4%
FY2025
Operating Margin
-1031.46%
FY2025
Diluted EPS
-$2.24
+66.2%
FY2025
Operating Cash Flow
-$81.63M
-58.4%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 |
|---|---|---|---|
| $10.32M | $9M | — | |
| $83.27M | $73.97M | $59.04M | |
| $28.76M | $27.81M | $19.16M | |
| $112.03M | $101.78M | $78.19M | |
| -$101.71M | -$92.78M | -$78.19M | |
| — | -1031.46% | — | |
| $481K | $697K | $2.37M | |
| $11.78M | $12.18M | $7.09M | |
| — | -$80.61M | -$71.11M | |
| — | $0 | $0 | |
| -$89.93M | -$80.61M | -$71.11M | |
| — | -896.11% | — | |
| -$90.12M | -$80.57M | -$71.03M | |
| USD/shares | — | -$2.24 | -$6.63 |
| USD/shares | — | -$2.24 | -$6.63 |
| shares | — | 35.93M | 10.73M |
| shares | — | 35.93M | 10.73M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Drug Manufacturers - Specialty & Generic median 2.14×
EV/EBIT
—
Drug Manufacturers - Specialty & Generic median 34.02×
P/E (TTM)
—
Drug Manufacturers - Specialty & Generic median 20.19×